Investigating how tau proteins contribute to frontotemporal dementia
Targeting Tau Proteoforms in Frontotemporal Dementia
This study is looking at how changes in a specific gene related to tau proteins might affect brain cells in people with frontotemporal dementia, using special cells from patients to find out more about how these proteins behave and how that could help develop new treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10795739 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of tau proteins in frontotemporal dementia, particularly how mutations in the MAPT gene affect tau aggregation and neuronal function. By using induced pluripotent stem cells derived from patients, the study examines differences in tau turnover and lysosomal function between mutant and control neurons. The goal is to uncover the mechanisms behind tauopathies and how they disrupt cellular processes, potentially leading to new therapeutic strategies for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a family history of frontotemporal dementia or those diagnosed with tauopathies linked to MAPT mutations.
Not a fit: Patients with tauopathies not associated with MAPT mutations or those with other forms of dementia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that target the underlying mechanisms of frontotemporal dementia, improving patient outcomes.
How similar studies have performed: Previous research has shown promising results in targeting tau proteins in related conditions, indicating potential for success in this approach.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Karch, Celeste Marie — Washington University
- Study coordinator: Karch, Celeste Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.